HR support officer - European Union Drugs Agency (FGIII, Lisbon)

About this position

The summary below is published by European Union Drugs Agency on the official vacancy notice. Our own analysis — salary realism, comparable openings, career trajectory, language profile — follows further down the page.

Position details

Reference

CA.2026.02

Last Verified

24 July 2026

Position overview

This is the official EU Careers listing for HR support officer at EUDA based in Lisbon at the FGIII grade level (Contract Agent). The vacancy reference is CA.2026.02.

[Skip to main content](https://www.euda.europa.eu/calls/2026/ca202602_en#main-content)

[Homepage](https://www.euda.europa.eu/)

[Quick links](https://www.euda.europa.eu/calls/2026/ca202602_en#block-block-menu-quick-links-menu)

## Quick links

* [Campaigns](https://www.euda.europa.eu/activities/campaigns_en "Currently active EMCDDA campaigns") * [Cannabis policy: recent developments](http://www.emcdda.europa.eu/topics/cannabis-policy) * [Data catalogue](https://www.euda.europa.eu/data/data-catalogue_en) * [Document library](https://www.euda.europa.eu/document-library_en "EMCDDA repository's of useful documents, mainly published by third-parties but also EMCDDA working documents etc.") * [Drug profiles](http://www.emcdda.europa.eu/drug-profiles) * [EU Early Warning System (EWS) on NPS](https://www.euda.europa.eu/archived/publications/topic-overviews/eu-early-warning-system_en) * [ESPAD](http://www.espad.org/ "(opens in a new window)") * [EU Drug Markets: In-depth analysis](https://www.euda.europa.eu/publications/eu-drug-markets_en) * [European Drug Report](https://www.euda.europa.eu/publications/european-drug-report/2026_en) * [European Responses Guide](https://www.euda.europa.eu/publications/health-and-social-responses-a-european-guide_en) * [Lisbon addictions](https://www.lisbonaddictions.eu/ "(opens in a new window)") * [Media library](https://www.euda.europa.eu/media-library_en) * [Network of labs](https://www.euda.europa.eu/activities/network-of-labs_en) * [Partners](http://www.emcdda.europa.eu/about/partners) * [Statistical Bulletin](https://www.euda.europa.eu/data/stats2026_en) * [Toolkits](https://www.euda.europa.eu/publications-database_en?f%5B0%5D=publication_type%3A3305 "Toolkits published by the EUDA") * [Web archive (up to 2 July 2024) — EMCDDA](https://wayback.archive-it.org/12090/*/https://www.emcdda.europa.eu/ "(Official archive of the EMCDDA website up to 2 July 2024, archived by the Publications Office of the European Union, opens in a new window)") * [Web archive (from 2 July 2024) — EUDA](https://wayback.archive-it.org/12090/*/https:/www.euda.europa.eu/ "(Official archive of the EUDA website from 2 July 2024, archived by the Publications Office of the European Union, opens in a new window)")

[](https://www.euda.europa.eu/calls/2026/ca202602_en#mainNavbar)

[](https://www.euda.europa.eu/index_en "Home")

The European Union Drugs Agency (EUDA)

English EN Select another language

[Toggle search form](https://www.euda.europa.eu/calls/2026/ca202602_en#mainNavbar)

GO Results hosted on duckduckgo.com

GO Results hosted on duckduckgo.com

## Main navigation

* [Data Open related submenu](https://www.euda.europa.eu/data_en)

### [Data](https://www.euda.europa.eu/data_en)

 Explore the most recent data on the drug situation in Europe provided by the EU Member States. These datasets underpin the analysis presented in the agency's work. Most data may be viewed interactively on screen and downloaded in Excel format.

[Data](https://www.euda.europa.eu/data_en)

### Latest data

* [Statistical Bulletin 2026 home](https://www.euda.europa.eu/data/stats2026_en) * [Prevalence of drug use](https://www.euda.europa.eu/data/stats2026/gps_en) * [Drug-induced deaths](https://www.euda.europa.eu/data/stats2026/drd_en) * [Infectious diseases](https://www.euda.europa.eu/data/stats2026/drid_en) * [Problem drug use](https://www.euda.europa.eu/data/stats2026/pdu_en) * [Treatment demand](https://www.euda.europa.eu/data/stats2026/tdi_en) * [Seizures of drugs](https://www.euda.europa.eu/data/stats2026/szr_en) * [Price, purity and potency](https://www.euda.europa.eu/data/stats2026/ppp_en)

* [Drug use and prison](https://www.euda.europa.eu/data/stats2026/dup_en) * [Drug law offences](https://www.euda.europa.eu/data/stats2026/dlo_en) * [Health and social responses](https://www.euda.europa.eu/data/stats2026/hsr_en) * [Drug checking (TEDI)](https://www.euda.europa.eu/data/stats2026/drug-checking_en) * [Hospital emergencies (Euro-DEN Plus)](https://www.euda.europa.eu/data/stats2026/hospital-emergencies_en) * [Syringe residues (ESCAPE)](https://www.euda.europa.eu/data/stats2026/syringe-residues_en) * [Wastewater analysis (SCORE)](https://www.euda.europa.eu/publications/html/pods/waste-water-analysis_en) * [Data catalogue](https://www.euda.europa.eu/data/data-catalogue_en)

* [Countries Open related submenu](https://www.euda.europa.eu/countries_en)

### [Countries](https://www.euda.europa.eu/countries_en)

 We work closely with the 27 EU Member States plus Norway and Türkiye, candidates and potential candidates to the EU, the European Neighbourhood Policy countries and other third countries.

[Countries](https://www.euda.europa.eu/countries_en)

### Reporting countries

* [Austria](https://www.euda.europa.eu/about/partners/reitox/austria_en) * [Belgium](https://www.euda.europa.eu/about/partners/reitox/belgium_en) * [Bulgaria](https://www.euda.europa.eu/about/partners/reitox/bulgaria_en) * [Croatia](https://www.euda.europa.eu/about/partners/reitox/croatia_en) * [Cyprus](https://www.euda.europa.eu/about/partners/reitox/cyprus_en) * [Czechia](https://www.euda.europa.eu/about/partners/reitox/czechia_en) * [Denmark](https://www.euda.europa.eu/about/partners/reitox/denmark_en) * [Estonia](https://www.euda.europa.eu/about/partners/reitox/estonia_en) * [Finland](https://www.euda.europa.eu/about/partners/reitox/finland_en) * [France](https://www.euda.europa.eu/about/partners/reitox/france_en)

* [Germany](https://www.euda.europa.eu/about/partners/reitox/germany_en) * [Greece](https://www.euda.europa.eu/about/partners/reitox/greece_en) * [Hungary](https://www.euda.europa.eu/about/partners/reitox/hungary_en) * [Ireland](https://www.euda.europa.eu/about/partners/reitox/ireland_en) * [Italy](https://www.euda.europa.eu/about/partners/reitox/italy_en) * [Latvia](https://www.euda.europa.eu/about/partners/reitox/latvia_en) * [Lithuania](https://www.euda.europa.eu/about/partners/reitox/lithuania_en) * [Luxembourg](https://www.euda.europa.eu/about/partners/reitox/luxembourg_en) * [Malta](https://www.euda.europa.eu/about/partners/reitox/malta_en) * [Netherlands](https://www.euda.europa.eu/about/partners/reitox/netherlands_en)

* [Norway](https://www.euda.europa.eu/about/partners/reitox/norway_en) * [Poland](https://www.euda.europa.eu/about/partners/reitox/poland_en) * [Portugal](https://www.euda.europa.eu/about/partners/reitox/portugal_en) * [Romania](https://www.euda.europa.eu/about/partners/reitox/romania_en) * [Slovakia](https://www.euda.europa.eu/about/partners/reitox/slovakia_en) * [Slovenia](https://www.euda.europa.eu/about/partners/reitox/slovenia_en) * [Spain](https://www.euda.europa.eu/about/partners/reitox/spain_en) * [Sweden](https://www.euda.europa.eu/about/partners/reitox/sweden_en) * [Türkiye](https://www.euda.europa.eu/about/partners/reitox/t%C3%BCrkiye_en)

[All countries](https://www.euda.europa.eu/countries)

* [Topics Open related submenu](https://www.euda.europa.eu/topics_en)

### [Topics](https://www.euda.europa.eu/topics_en)

 Explore the content of our work by topic.

[Topics](https://www.euda.europa.eu/topics_en)

### Selected topics

* [Alternatives to coercive sanctions](https://www.euda.europa.eu/content/alternatives-coercive-sanctions_en) * [Cannabis](https://www.euda.europa.eu/topics/cannabis_en) * [Cannabis policy](https://www.euda.europa.eu/topics/cannabis-policy_en) * [Cocaine](https://www.euda.europa.eu/topics/cocaine_en) * [Darknet markets](https://www.euda.europa.eu/topics/darknet-and-drugs_en) * [Drug checking](https://www.euda.europa.eu/topics/drug-checking_en) * [Drug consumption facilities](https://www.euda.europa.eu/topics/drug-consumption-facilities_en) * [Drug markets](https://www.euda.europa.eu/topics/drug-markets_en) * [Drug-related deaths](https://www.euda.europa.eu/topics/drug-related-deaths_en) * [Drug-related infectious diseases](https://www.euda.europa.eu/topics/drug-related-infectious-diseases_en)

* [Drug markets-related violence](https://www.euda.europa.eu/topics/drug-related-violence-hub-page_en) * [Drugs and driving](https://www.euda.europa.eu/topics/drugs-and-driving_en) * [European Web Survey on Drugs](https://www.euda.europa.eu/topics/european-web-survey-on-drugs_en) * [Gender and drugs](https://www.euda.europa.eu/topics/gender-and-drugs_en) * [Harm reduction](https://www.euda.europa.eu/topics/harm-reduction_en) * [Heroin](https://www.euda.europa.eu/topics/heroin_en) * [Hospital emergencies](https://www.euda.europa.eu/topics/hospital-emergencies_en) * [Law](https://www.euda.europa.eu/topics/law_en) * [Naloxone](https://www.euda.europa.eu/topics/naloxone_en) * [New psychoactive substances (NPS)](https://www.euda.europa.eu/topics/nps_en)

* [Prevalence of drug use](https://www.euda.europa.eu/topics/prevalence-and-pat

Salary at this grade

Basic monthly salary at FGIII runs from €3,476 (step 1) to €3,932 (top step), giving an annual range of roughly €41,712 to €47,184 before tax and allowances. Steps increase automatically every two years; the figures here are taken from the salary grid in the EU Staff Regulations.

Eligible staff posted away from their country of nationality also receive an expatriation allowance worth 16% of basic salary (around €556 per month at step 1 of FGIII) together with household, dependent-child, and education allowances where applicable. Take-home pay is then adjusted by the country correction coefficient for Lisbon. For a worked example see our correction coefficients guide and the EU salaries overview.

Application timeline

This vacancy was first listed on 28 May 2026, 68 days ago.

The deadline of 29 May 2026 has now passed and this position is no longer accepting applications. Browse other current openings via the links below.

Last verified against the EU Careers feed on 24 July 2026 (11 days ago).

Where to learn more

For full responsibilities, requirements, and career progression at FGIII see our FGIII grade page; for headcount, mission, and other open vacancies at EUDA see the EUDA institution page; for the cost of living, correction coefficient, and other postings in Lisbon see our Lisbon location page.

New to EU careers? Our beginner's guide walks through entry routes, EPSO competitions, and what to prepare. For application logistics see application tips and EPSO competitions.